HomeADIL • NASDAQ
add
Adial Pharmaceuticals Inc
Previous close
$1.02
Day range
$0.99 - $1.04
Year range
$0.78 - $4.17
Market cap
6.60M USD
Avg Volume
168.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.21M | 62.86% |
Net income | -2.19M | -58.26% |
Net profit margin | — | — |
Earnings per share | -0.38 | 66.67% |
EBITDA | -2.21M | -62.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.20M | 1,547.57% |
Total assets | 6.71M | 134.10% |
Total liabilities | 829.05K | 56.96% |
Total equity | 5.88M | — |
Shares outstanding | 6.41M | — |
Price to book | 1.11 | — |
Return on assets | -94.82% | — |
Return on capital | -108.83% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.19M | -58.26% |
Cash from operations | -1.69M | -21.79% |
Cash from investing | — | — |
Cash from financing | 3.61M | 2,503.61% |
Net change in cash | 1.92M | 312.37% |
Free cash flow | -915.49K | -81.38% |
About
Founded
2010
Headquarters
Website
Employees
6
